Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-Analysis.

Front Oncol · 2021 · PMC8691653 · PMID 34950579

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend toward significanceno p-value reported

Among included treatments, first generation TKI (gefitinib) plus chemotherapy ranked first in improving overall survival (P score=0.91) and showed a trend toward significance (HR=0.72, 95%CI 0.40-1.27) ( Figure 2C ) ( Supplement C , Figure S4 ).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.